Where Will Aurora Cannabis (TSX:ACB) Be in 5 Years?

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) has done very well since going public, but with losses piling up, where does it go from here?

| More on:

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) is one of many weed stocks that fell from grace in mid-late 2019. After reaching a high of $13.26 in March, it began a steep, months long tumble, at one point falling as low as $7.78.

In August, the stock has been on a minor upswing, having regained about 11% of its value since the start of the month, but it remains way down from its 52 week highs.

Marijuana stocks are known for their volatility, and Aurora is no exception. With a beta coefficient of 2.59, it’s more than twice as volatile as the TSX index, which makes trying to anticipate future prices for the stock difficult.

However, it’s possible to gauge whether the ACB’s long term trajectory will be positive or negative. We can start with the company’s most recent financial results.

Huge growth, but continued losses

In all of its recent quarters, Aurora has posted massive year-over-year revenue growth. In Q3, for example, it reported $75 million in sales, up 367% from the same quarter a year before and 21% from the prior quarter.

That’s impressive growth, but it should be mentioned that the company continues to run large losses: in Q3, the loss attributable to shareholders stood at $158 million. The good news is that this loss was down from Q2, when the company lost $237 million.

However, it’s still enormous as a percentage of revenue.

Digging deeper

When evaluating profits and losses in a company like Aurora, it makes sense to separate net results from operating results. After all, cannabis companies own huge amounts of biological assets, whose fair value can be re-assessed resulting in financial losses that don’t reflect operating performance.

In Aurora’s case, the most recent quarter’s operating loss was $75 million–far lower than its net loss and also less than revenue. The operating loss is also down from Q1, when the company lost $96 million from operations.

These results would tend to predict a slimming of long-term losses and perhaps a gradual move toward profitability.

Valuation

Now we get to the bad news:

At current prices, Aurora stock costs about 53 times (ttm) sales, making it an extraordinarily expensive stock even with all the revenue growth it’s been seeing.

Although the price-to-book ratio of 2 is not insanely high, we’ve got a stock here that’s not generating positive earnings and whose price-to-sales ratio would be high even if it were a P/E ratio.

At minimum, this indicates that Aurora will need to keep up its six figure revenue growth for a long time to justify its price.

Given all that, it seems fairly unlikely that Aurora will keep up its past returns over the next five years. The stock has gotten extremely expensive and although its revenue growth is sky high, it will probably slow down once the ‘legalization boost’ slips further and further from view.

Remember that in Aurora’s 2019 quarterly reports, it compares post-legalization sales to pre-legalization sales. Once legalization is a full year into the past, the company’s revenue growth will almost certainly decelerate.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »